METTL14’s downstream target was lncRNA XIST, according to Xiao Yang et al. Down-regulation of oncogenic lncRNA XIST via METTL14 inhibited CRC cell metastasis and growth; thus, METTL14 may be a promising therapeutic target [121]. The gene discussed is XIST; the disease is colorectal carcinoma.